Patient leaflet - Staquis
1. What Staquis is and what it is used for
Staquis contains the active substance crisaborole. Staquis is used on the skin to control the symptoms of mild to moderate atopic dermatitis in adults and children from 2 years of age. Atopic dermatitis, also called atopic eczema, causes skin inflammation, redness, itchiness, dryness, and thickening in people prone to allergies. The ointment should not be used on more than 40% of your body surface area.
Crisaborole, the active substance in Staquis, is thought to work by reducing inflammation and some effects of the immune system (the body’s defences).
2. What you need to know before you use Staquis
Do not use Staquis
- if you are allergic to crisaborole or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Talk to your doctor or pharmacist before using Staquis.
Staquis is not for use in the eyes, mouth, or vagina; therefore, take care not to get this ointment into these areas. If the ointment accidentally gets into these areas, thoroughly wipe off and/or rinse off the ointment with water.
Stop using Staquis immediately and see your doctor if you get an allergic reaction. Symptoms include welts (hives), itching, swelling, and redness that are severe.
Skin reactions where this medicine is applied, such as burning or stinging, may be more likely to occur on sensitive skin areas such as the face and neck.
Children
Staquis has not been studied in children younger than 2 years of age; therefore, it should not be used in this group of children. Speak to your doctor, pharmacist, or nurse.
Other medicines and Staquis
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Some medicines can affect the levels of Staquis in your body. You should inform your doctor if you are taking medicines containing the following active substances:
- ketoconazole, itraconazole (used to treat fungal infections)
- erythromycin, clarithromycin, ciprofloxacin (used to treat infections)
- ritonavir (used to treat HIV)
- fluvoxamine (used to treat depression).
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. The effects of this medicine in pregnant women are not known; therefore, do not use Staquis in pregnancy unless you have checked with your doctor that you can use it.
It is not known if Staquis passes into the milk after applying it to the skin. The effects of this medicine in breastfed infants are not known; therefore, Staquis should not be used if you are breast-feeding or are planning to breast-feed.
Driving and using machines
Staquis is unlikely to have an effect on your ability to drive and use machines.
Staquis contains propylene glycol
in each gram of ointment.
This medicine contains 90 mg propylene
3. How to use Staquis
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Use in adults
- Apply a layer of the ointment twice daily to affected areas of your skin.
- This medicine can be used on all skin areas except on the scalp.
- The ointment should only be used on up to 40% of your body surface area.
Wash your hands after applying this medicine, unless it is your hands that are being treated. If someone else applies this medicine to you, they should wash their hands after application.
This medicine can be used twice daily for up to 4 weeks per treatment course. As instructed by your doctor, you can use further treatment course(s) if your atopic dermatitis is not controlled or appears on new areas as long as you do not apply the ointment to more than 40% of your body surface area. If your atopic dermatitis is still there after 12 weeks of therapy, or if your atopic dermatitis gets worse, stop using the medicine and see your doctor.
Moisturisers (emollients) may be used on areas of the skin where Staquis is not applied. Do not use other topical medicines (such as ointments, creams, lotions) on areas of the skin where Staquis is applied without asking your doctor.
Use in children and adolescents
For children 2 years of age and older, and adolescents the instructions for use are the same as for adults.
If you use more Staquis than you should
If too much Staquis has been applied, the excess should be wiped off.
If you forget to use Staquis
If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue your normal dosing schedule.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Allergic reactions may occur uncommonly. Allergic reactions include severe ms of:
- hives
- itching
- swelling
- redness.
y and talk with your doctor or
If you have an allergic reaction, stop using this medicine im pharmacist.
Other side effects may include:
Common (may affect up to 1 in 10 people)
- Skin reactions where this medicine is applied such as pain (burning or stinging), itching, rash, redness, irritation, and hives.
The most common skin reaction, pain (burning or stinging), is usually mild to moderate and generally goes away after several applications.
Uncommon (may affect - Allergic reaction in 100 people) des severe symptoms of hives, itching, swelling, and redness.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the s medicine.
5. How to store Staquis
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the tube and carton after “EXP”. The expiry date refers to the last day of that month.
Do not store above 25 °C. Do not freeze.
Once opened, use the tube within 1 year.
Keep the tube tightly closed.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Staquis contains
- The active substance is crisaborole.
One g of ointment contains 20 mg of crisaborole.
The other ingredients are paraffin, white soft; propylene glycol (E 1520 [see section 2]); glycerol monostearate 40-55 (Type I); paraffin, hard; sodium calcium edetate.
What Staquis looks like and contents of the pack
Staquis is a white to off-white ointment. It is supplied in 2.5 g, 30 g, 60 g, and 100 g laminate tubes. There are six tubes per carton for the 2.5 g tubes. There is one tube per carton for the 30 g, 60 g, and 100 g tubes. Not all tube sizes may be marketed.
Each tube comes with a tube head with a peel seal, and a white cap closure.
Marketing Authorisation Holder
Pfizer Europe MA EEIG
Boulevard de la Plaine 17
1050 Bruxelles
Belgium
Manufacturer
Pfizer Service Company BVBA
Hoge Wei 10
1930 Zaventem
Belgium
For any information about this me Authorisation Holder:
please contact the local representative of the Marketing
België/Belgique/Belgien
Pfizer S.A. / N.V.
Tél/Tel: +32 (0)2 554 62 11
Lietuva
Pfizer Luxembourg SARL filialas Lietuvoje
Tel. +3705 2514000
Efc^rapufl n$aň3ep ^ Khoh Bmf;
6ypr CÀP^,
Luxembourg/Luxemburg
Pfizer S.A. / N.V.
Tél/Tel: +32 (0)2 554 62 11
Česká republika
Pfizer, spol. s r.o.
Tel: +420 283 004 111
Magyarország
Pfizer Kft.
Tel: +36 1 488 3700
Danmark
Pfizer ApS
Tlf: +45 44 20 11 00
Malta
Vivian Corporation Ltd
Tel: +35621 344610
Deutschland
Pfizer Pharma GmbH
Tel: +49 (0)30 550055-51000
Nederland
Pfizer bv
Tel: +31 (0)10 406 43 01
Eesti
Pfizer Luxembourg SARL Eesti filiaal
Tel: +372 666 7500
Norge
Pfizer AS
Tlf: +47 67 526 100
EÀÀàôa
PFIZER EAAAZ A.E.
TqX.: +30 210 67 85 800
España
Pfizer, S.L.
Tel: +34 91 490 99 00
France
Pfizer
Tél +33 (0)1 58 07 34 40
Hrvatska
Pfizer Croatia d.o.o.
Tel: +385 1 3908 777
Österreich
Pfizer Corporation Austria Ges.m.b.H.
Tel: +43 (0)1 521 15-0
Polska
Pfizer Polska Sp. z o.o.
Tel.: +48 22 335 61 00
Portugal
Laboratórios Pfizer, Lda.
Tel: (+351) 21 423 55 00
Româ
Pfizer Romania S.R.L
Ireland
Pfizer Healthcare Ireland
Tel: +1800 633 363 (toll free)
Tel: +44 (0)1304 616161
Italia
Pfizer S.r.l.
Tel: +3
Ísland
Icepharma hf.
Tel: +354 540 8000
Kùnpi
PFIZER EAAAZ A.E. (CYPRUS BRANCH)
Trik +357 22 817690
Slovenija
Pfizer Luxembourg SARL
Pfizer, podružnica za svetovanje s področja farmacevtske dejavnosti, Ljubljana
Tel: +386 (0)1 52 11 400
Slovenská republika
Pfizer Luxembourg SARL, organizačná zložka
Tel: +421 2 3355 5500
Suomi/Finland
Pfizer Oy
Puh/Tel: +358 (0)9 430 040
Sverige
Pfizer AB
Tel: +46 (0)8 550 520 00
Latvija
Pfizer Luxembourg SARL filiale Latvijä
Tel. +371 67035775
United Kingdom (Northern Ireland)
Pfizer Limited
Tel: +44 (0)1304 616161
This leaflet was last revised in
Detailed information on this medicine is available on the European Medicines Agency web site: http : //www .ema.europa.eu.
29
